Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IVERIC bio, Inc. (OPHT)
|
Add to portfolio |
|
|
|
| Price: |
$5.77
| | Metrics |
| OS: |
137.8
|
M
| |
|
|
| Market cap: |
$795
|
M
| |
|
|
|
Net cash:
|
$371
|
M
| |
$2.69
|
per share
|
|
EV:
|
$424
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($142)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 192.3 | 0.0 | 0.0 | 0.0 | 0.0 | 210.0 | 50.9 | 51.5 |
| Revenue growth | | | | | -100.0% | 312.5% | -1.2% | 24.8% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 192.3 | 0.0 | 0.0 | 0.0 | 0.0 | 210.0 | 50.9 | 51.5 |
| Gross margin | 100.0% | | | | | 100.0% | 100.0% | 100.0% |
| Research and development | 117.0 | 85.1 | 62.8 | 39.6 | 41.7 | 66.3 | 196.3 | 131.0 |
| General and administrative | 72.9 | 29.7 | 26.0 | 21.6 | 23.6 | 35.7 | 50.2 | 44.0 |
| EBIT | -187.5 | -114.8 | -88.7 | -61.3 | -65.3 | 108.0 | -195.6 | -123.5 |
| EBIT margin | -97.5% | | | | | 51.4% | -384.1% | -239.8% |
| Pre-tax income | -185.2 | -114.5 | -88.2 | -59.0 | 62.0 | 109.5 | -193.8 | -122.5 |
| Income taxes | 0.0 | 0.0 | -3.7 | -0.1 | -1.1 | -4.7 | -0.4 | -16.8 |
| Tax rate | 0.0% | 0.0% | 4.2% | 0.2% | | | 0.2% | 13.7% |
| Net income | -185.2 | -114.5 | -84.5 | -58.9 | 63.1 | 114.2 | -193.4 | -105.7 |
| Net margin | -96.3% | | | | | 54.4% | -379.9% | -205.3% |
| |
| Diluted EPS | ($1.53) | ($1.12) | ($1.14) | ($1.39) | $1.70 | $3.17 | ($5.45) | ($3.06) |
| Shares outstanding (diluted) | 121.0 | 101.9 | 74.2 | 42.2 | 37.1 | 36.0 | 35.5 | 34.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|